To investigate whether ST2+ Treg cells preferentially kill TME-derived CD8 T cells, we cocultured ex vivo sorted ST2+ Treg cells from leukemia mice with BM-derived CD8 T cells from naïve versus non-tumoral versus tumoral mice at increasing Treg:CD8 ratios. This evidence concerns the gene IL1RL1 and leukemia.